Hu-Lin Jiang (Hulin Jiang)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

Science advances

Advanced materials (Deerfield Beach, Fla.)

Chemical communications (Cambridge, England)

Molecular pharmaceutics

Seoul National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Seoul National University Sep 1o 2004 - Feb 28o 2008

South Korea

PHD

Publications

Meng-Meng Han, Xing-Yue He, Ling Tang, Liang Qi, Ming-Yuan Yang, Yi Wang, Lei Xing, Jee-Heon Jeong, Hu-Lin Jiang
Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice. Science advances 9 (29) (2023)
Tian-Tian Zhao, Tian-Jiao Zhou, Chen Zhang, Ying-Xuan Liu, Wen-Jia Wang, Chengjun Li, Lei Xing, Hu-Lin Jiang
Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma. Molecular pharmaceutics (2023)
Ying Sun, Lei Xing, Jun Luo, Ming-Tao Yu, Xiao-Jie Wang, Yi Wang, Tian-Jiao Zhou, Hu-Lin Jiang
A Pro-Metastatic Derivatives Eliminator for In Vivo Dual-Removal of Circulating Tumor Cells and Tumor-Derived Exosomes Impedes their Biodistribution into Distant Organs. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Ling-Feng Zhang, Xing-Huan Wang, Cheng-Lu Zhang, Jaiwoo Lee, Bo-Wen Duan, Lei Xing, Ling Li, Yu-Kyoung Oh, Hu-Lin Jiang
Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy. ACS nano 16 (9) (2022)
Tiep Tien Nguyen, Duc-Vinh Pham, Junhyeung Park, Cao Dai Phung, Mahesh Raj Nepal, Mahesh Pandit, Manju Shrestha, Youlim Son, Mili Joshi, Tae Cheon Jeong, Pil-Hoon Park, Dong-Young Choi, Jae-Hoon Chang, Jong Oh Kim, Jae-Ryong Kim, Il-Kug Kim, Chul Soon Yong, Jong Oh Kim, Jong-Hyuk Sung, Hu-Lin Jiang, Hyung-Sik Kim, Simmyung Yook, Jee-Heon Jeong
Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation. Science advances 8 (34) (2022)
Jianbing Wu, Tao Sun, Chenxi Yang, Tian Lv, Yuyang Bi, Yuan Xu, Yong Ling, Jun Zhao, Rigang Cong, Yihua Zhang, Jianhua Wang, Hao Wen, Hu-Lin Jiang, Fei Li, Zhangjian Huang
Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide in vivo. Biomaterials science 9 (5) (2021)
Yi Wang, Li-Fan Hu, Peng-Fei Cui, Lian-Yu Qi, Lei Xing, Hu-Lin Jiang
Pathologically Responsive Mitochondrial Gene Therapy in an Allotopic Expression-Independent Manner Cures Leber's Hereditary Optic Neuropathy. Advanced materials (Deerfield Beach, Fla.) 33 (41) (2021)
Tian-Jiao Zhou, Yuan Xu, Lei Xing, Yi Wang, Hu-Lin Jiang
A Harmless-Harmful Switchable and Uninterrupted Laccase-Instructed Killer for Activatable Chemodynamic Therapy. Advanced materials (Deerfield Beach, Fla.) 33 (27) (2021)
Chen-Xi Yang, Lei Xing, Xin Chang, Tian-Jiao Zhou, Yu-Yang Bi, Zhi-Qiang Yu, Zhi-Qi Zhang, Hu-Lin Jiang
Synergistic Platinum(II) Prodrug Nanoparticles for Enhanced Breast Cancer Therapy. Molecular pharmaceutics 17 (4) (2020)
Xin Chang, Lei Xing, Yi Wang, Chen-Xi Yang, Yu-Jing He, Tian-Jiao Zhou, Xiang-Dong Gao, Ling Li, Hai-Ping Hao, Hu-Lin Jiang
Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis. Science advances 6 (22) (2020)
Liu-Qing Gu, Peng-Fei Cui, Lei Xing, Yu-Jing He, Xin Chang, Tian-Jiao Zhou, Yu Liu, Ling Li, Hu-Lin Jiang
An energy-blocking nanoparticle decorated with anti-VEGF antibody to reverse chemotherapeutic drug resistance. RSC advances 9 (21) (2019)
Lei Xing, Jia-Liang Zhang, Tian-Jiao Zhou, Yu-Jing He, Peng-Fei Cui, Jia-Hui Gong, Minjie Sun, Jin-Jian Lu, Zhangjian Huang, Liang Jin, Hu-Lin Jiang
A novel design of a polynuclear co-delivery system for safe and efficient cancer therapy. Chemical communications (Cambridge, England) 54 (63) (2018)
Zhanwei Zhou, Huipeng Li, Kaikai Wang, Qian Guo, Chenzi Li, Hu-Lin Jiang, Yiqiao Hu, Minjie Sun, Minjie Sun
Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy. ACS applied materials & interfaces 9 (17) (2017)
Lei Xing, Jin-Yuan Lyu, Yue Yang, Peng-Fei Cui, Liu-Qing Gu, Jian-Bin Qiao, Yu-Jing He, Tian-Qi Zhang, Minjie Sun, Jin-Jian Lu, Xiaojun Xu, Yu Liu, Hu-Lin Jiang
pH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy. Chemical communications (Cambridge, England) 53 (62) (2017)

Hu-Lin Jiang.css-eqlu8i{font-size:small;padding-left:4px;} (Hulin Jiang)

Publication Activity (10 Years)

Top Topics

Top Venues

Hu-Lin Jiang (Hulin Jiang)